应用
选项
-
Datopotamab deruxtecan (anti-TROP2)关联靶标: TACSTD2简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-GGFG-DXd)种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-GGFG-DXdCAS号: 2238831-60-0SMILES: [Datopotamab deruxtecan]
-
Pinatuzumab vedotin (anti-CD22)关联靶标: CD22简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 1313706-14-7
-
Abbott patent anti-NGR (anti-NGR)关联靶标: RTN4R简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1-REM-FEA; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 大鼠(Rat) 亚型: Human IgG1-REM-FEA宿主种属: 人(Human) 偶联: Unconjugated
首页
400-620-6333


